Open Orphan Share Discussion Threads

[sikhthetech] 28/6/2022 18:27

Said before, this was pumped/dumped by the gang with their multiple ids...

[chica1] 28/6/2022 15:00

The Orphan Army's dead bodies are strewn all over the AIM Exchange. They got bad intelligence from our Mr.Friel.

[jeanesy] 28/6/2022 14:04

Down to new year lows now :(

[bonagratia] 28/6/2022 12:14

Market going up....ORPH going down. The wisdom of crowds.

[chica1] 28/6/2022 10:40

💤💤💤💤8164;😒ԅ30;😒😒;😒

[m5] 27/6/2022 14:54

Looks like, dare I say it, the bottom. Disappointing we are not seeing some uplift from here. Be nice to see MO splash the cash.

[1gw] 26/6/2022 22:00

Customer Concentration. This is a red herring in my opinion. The relevant section of the AR is this: "During the period ended 31 December 2021, the Company had four customers, out of more than 30 customers, who each generated revenue greater than 10% of total revenue which was £30m. These customers generated 34%, 14%, 13% and 11% of revenue respectively." It is talking about hVivo business. 34% of £30m is £10.2m. 14% of £30m is £4.2m. So all it's saying is that they had £10.2m of business with their biggest customer. That is 1 large contract or 2 smaller ones. Remember they've just signed a £14.7m contract. The second biggest customer last year, at £4.2m, isn't even a particularly large single contract this year. The issue, I think, is more that their business is still relatively lumpy. If total hVIVO revenue last year was £30m, and this year might be £40m or so (out of the £50m total guided) then they can't fit in many £10m contracts, and each one is going to be a big percentage of the year's business. There's no reason why they can't make a good operating margin on those large contracts if there is competition for the bed space in the clinics. But if one of those large contracts gets delayed at the last minute then they may well have a problem filling the beds at short notice.

[sev22] 26/6/2022 17:05

https://youtu.be/DTonu3KTL7A

[sev22] 26/6/2022 17:01

https://youtu.be/DTonu3KTL7A

[m5] 26/6/2022 13:26

https://twitter.com/Eskers1/status/1541018392227991553

[sikhthetech] 25/6/2022 13:00

1gw, It's good I managed to get you to come out of your hiding place. You still haven't commented on the results. It's odd how you and your mates go quiet when the going gets tough. Trying to act the victim and all innocent, blame the management etc..lol Why can't you be honest for once? Have you and your mates dumped a load of shares after the pump and dump?. sikhthetech22 Jun '22 - 14:54 - 4111 of 4118 Edit 1gw You haven't said anything about the results? Not good were they, so I suppose it's best to keep quiet and save the embarrassment. Are you and your mates now dumping these on the quiet???

[bonagratia] 24/6/2022 15:56

Just looking at this one for the first time, seems like good value and a good time to buy. Can anyone recommend it, how much money have y'all made on it? The Chairman certainly seems like a smart cookie.

[rafboy] 23/6/2022 15:09

I’ll take blue in these markets.

[m5] 23/6/2022 15:03

Here we go, 20p by end of business tomorrow!!! I can dream.

[m5] 23/6/2022 14:23

Seem to be pretty stable anyway. Still respecting that long term term trendline and DB. Every cloud.

[sev22] 23/6/2022 08:02

https://www.proactiveinvestors.co.uk/companies/news/985451/open-orphan-a-london-listed-leader-clinical-challenge-studies-985451.html

[sev22] 23/6/2022 08:02

https://www.proactiveinvestors.co.uk/companies/news/985451/open-orphan-a-london-listed-leader-clinical-challenge-studies-985451.html

[1gw] 22/6/2022 17:00

Yes, I saw that. But even if he is still with the company and committed to it, there is likely to be a material cost in exercising the options in full, and the "usual" thing I think would be to do some sort of cashless exercise where sufficient shares are sold to fund the exercise cost and tax payable. It just might provide Mo with an opportunity to pick up a meaningful stake though.

[chica1] 22/6/2022 16:46

Maurice Treacy LinkedIn still CCO apparently and active on LinkedIn promoting Hvivo,Open Orphan. hxxps://www.linkedin.com/in/maurice-treacy-5b561637?trk=public_profile_browsemap_mini-profile_title&originalSubdomain=ie

[1gw] 22/6/2022 16:40

So here's a thing. According to the annual report, there are options over 7.7m shares, granted on 28th June 2019, which had 0.5 years left to run at 31st December 2021. The exercise price is 5.6p, so still in the money. Looking back to the 2019 annual report, it appears these belong (having vested) to Maurice Treacy, the former (and maybe even current) Chief Commercial Officer. AFAICS he has continued posting about Open Orphan achievements and talking about "we" since he resigned as a director in January 2020 (completion of hVIVO reverse), so may still be with the company if not on the board. There hasn't been an "Exercise of Options" RNS since 10th December. So it looks to me as though those options stand to be exercised by around the end of this month (perhaps by 28th). Because they are not at a nominal (or zero) exercise price, there is a non-trivial cost to exercise (5.6p/share) and I think there will be a material tax cost as well on the gain upon exercise. If he wants (or is required by the terms of the scheme) to sell sufficient shares upon exercise to cover the cost of the ones he keeps and the tax payable, then that is going to be quite a chunky sale. And if he wants to sell all of them then even more so. Could that be weighing on the price? Alternatively could that be a source of shares for Mo if he is allowed (and willing) to commit?

[jeanesy] 22/6/2022 14:59

Sadly this is at new yearly lows and going lower. No sign of MO buying any shares and no statement to say we know no reason. 10p and below now very close !

[sikhthetech] 22/6/2022 14:54

1gw You haven't said anything about the results? Not good were they, so I suppose it's best to keep quiet and save the embarrassment. Are you and your mates now dumping these on the quiet???

[allenquatermain] 22/6/2022 14:47

11p That’s funny big mouth Oreilly has gone quiet HILARIOUS